Study guide

8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data

Certified Pulmonary Function Technologist CPFT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & NBRC Certification Requirements

1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

2 Chapter 2: Spirometry Equipment & Sensors

2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification

3 Chapter 3: Body Plethysmography & Hardware

3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography

4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control

4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices

5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria

5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

6 Chapter 6: Lung Volume Determination Protocols

6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods

7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education

8 Chapter 8: Cardiopulmonary Exercise & ABG Testing

8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis

9 Chapter 9: Reference Values & PFT Calculations

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations

10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation

10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols

11 Chapter 11: Artifact Recognition & Quality Assurance

11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance

12 Chapter 12: Documentation, Compliance, & Emergency Safety

12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab

13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data

13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management

8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data

Key Takeaways Explain This Topic AI

Pulse oximetry measures functional saturation from two wavelengths and is blind to carboxyhemoglobin and methemoglobin, whereas CO-oximetry measures fractional saturation using multiple wavelengths.

FDA-cleared oximeters carry an accuracy root-mean-square within 3% over the 70 to 100% range, so a displayed 90% represents a true saturation roughly between 87% and 93%.

The oxyhemoglobin dissociation curve is steep below an SpO2 of about 90%, so small further drops in saturation reflect large drops in PaO2 and small saturation gains restore large PaO2 gains.

Occult hypoxemia is more frequent in patients with darker skin pigmentation, so a borderline SpO2 driving an oxygen prescription should be confirmed against arterial or capillary blood gas measurement.

Long-term oxygen therapy qualification in the United States is based on a resting PaO2 of 55 mmHg or less, or an SpO2 of 88% or less, or 56 to 59 mmHg with cor pulmonale, polycythemia, or edema.

Last updated: August 2026

8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data

Pulse oximetry occupies four separate cells of the PFT Detailed Content Outline: it is a Domain I equipment category (item 19a), a Domain II procedure (item 14), and a Domain III data topic (item 11) examined for calculation, reliability, and clinical implication. Oxygen assessment and titration at rest and/or exercise is a fifth (Domain II item 12, Domain III item 7). Together they generate more scored items than blood gas analysis, which is capped at three per form.

Functional Versus Fractional Saturation

This distinction is the conceptual core of the topic.

Functional saturation — what a two-wavelength pulse oximeter reports: S p O 2 = O 2 H b O 2 H b + H H b × 100 SpO_2 = \frac{O_2Hb}{O_2Hb + HHb} \times 100 Sp O 2 ​ = O 2 ​ H b + HH b O 2 ​ H b ​ × 100

Fractional saturation — what a multi-wavelength CO-oximeter reports: S a O 2 (fractional) = O 2 H b O 2 H b + H H b + C O H b + M e t H b × 100 SaO_2 \text{(fractional)} = \frac{O_2Hb}{O_2Hb + HHb + COHb + MetHb} \times 100 S a O 2 ​ (fractional) = O 2 ​ H b + HH b + CO H b + M e t H b O 2 ​ H b ​ × 100

A conventional pulse oximeter has only two unknowns to solve for because it has only two wavelengths, so it assumes that all hemoglobin is either oxygenated or reduced. Every dyshemoglobin present is therefore forced into one of those two buckets. That single assumption generates the two classic traps:

Carboxyhemoglobin absorbs 660 nm light almost identically to oxyhemoglobin, so the oximeter counts it as saturated. SpO 2 _2 2 ​ reads falsely high — often 98–100% in a patient with life-threatening carbon monoxide poisoning.

Methemoglobin absorbs strongly at both 660 nm and 940 nm, driving the ratio-of-ratios toward 1.0, which corresponds to about 85% . As methemoglobinemia worsens, the SpO 2 _2 2 ​ does not keep falling; it plateaus near 85% regardless of the true saturation. A saturation gap between a pulse oximeter reading 85% and a co-oximeter reading much lower is the diagnostic signature.

The Accuracy Envelope and Why It Matters Clinically

FDA clearance for a prescription pulse oximeter requires an accuracy root-mean-square ( A R M S _{RMS} RMS ​ ) of within 3% across 70–100% saturation, validated against arterial CO-oximetry in controlled desaturation studies. Below 70%, the calibration curve is extrapolated rather than measured.

An A R M S _{RMS} RMS ​ of 3% means a displayed 90% corresponds to a true saturation roughly in the 87–93% range. That envelope straddles every clinically important oxygen threshold, which is why a borderline reading that will drive an oxygen prescription should be confirmed with an arterial or arterialized capillary sample.

Occult hypoxemia. Multiple large studies have shown that pulse oximeters over-read true arterial saturation more often in patients with darker skin pigmentation, so a patient can have an SpO 2 _2 2 ​ at or above 92% while true SaO 2 _2 2 ​ is below 88%. The technologist's obligation is not to apply a correction factor — none is validated — but to lower the threshold for confirmatory blood gas measurement whenever a saturation-based decision is being made, and to document that the reading was device-derived.

Why the 88–90% Threshold Exists

The oxyhemoglobin dissociation curve is flat above a PaO 2 _2 2 ​ of about 60 mmHg and steep below it . At an SpO 2 _2 2 ​ of 90%, PaO 2 _2 2 ​ is approximately 60 mmHg; at 88%, roughly 55 mmHg; at 75%, roughly 40 mmHg (the classic 40/50/60 = 75/80/90 landmarks). On the steep portion, a two-point drop in saturation represents a large drop in dissolved oxygen tension — and conversely, a small amount of supplemental oxygen produces a large PaO 2 _2 2 ​ gain. Titration targets sit at 88–90% because that is where the curve turns.

Artifacts and Troubleshooting

Artifact Direction of Error Recognition and Remedy

Motion (walking, tremor) Falsely low Erratic waveform; use a forehead or earlobe probe, or a motion-tolerant algorithm

Low perfusion / cold / hypotension Erratic, drifts toward 85% Weak pulse amplitude; warm the site, move proximally

  • Dark nail polish, artificial nails Falsely low Remove, or rotate the probe 90° so light passes laterally
  • Ambient light Unstable or falsely high Shield the probe

Venous pulsation (tricuspid regurgitation, probe too tight, dependent limb) Falsely low Loosen the probe, elevate the limb

Intravascular dyes (methylene blue, indocyanine green) Transient sharp fall Wait; effect is minutes-long

Severe anemia SpO 2 _2 2 ​ can be normal while content is critically low Saturation is a percentage, not a quantity — check hemoglobin

The single most useful habit: confirm that the displayed pulse rate matches a palpated or ECG rate , and look at the plethysmographic waveform or perfusion index before accepting any saturation value. A saturation number with no valid pulse behind it is meaningless.

  • Oxygen Assessment and Titration
  • Resting Assessment and Long-Term Oxygen Therapy Qualification

United States qualification criteria for long-term oxygen therapy, measured at rest, on room air, in a clinically stable patient:

PaO 2 _2 2 ​ ≤ \le ≤ 55 mmHg or SpO 2 _2 2 ​ ≤ \le ≤ 88% ; or

PaO 2 _2 2 ​ 56–59 mmHg or SpO 2 _2 2 ​ = 89% with evidence of cor pulmonale, right heart failure with dependent edema, or polycythemia (hematocrit > 56%) .

Qualification testing must be performed on room air after the patient has been off supplemental oxygen long enough to reach a steady state (commonly 20–30 minutes when clinically safe), and the exact conditions must be documented.

Exertional Assessment and Titration

Exertional desaturation is defined as an SpO 2 _2 2 ​ fall of at least 4% from baseline, or an absolute SpO 2 _2 2 ​ below 88% , during activity such as a six-minute walk.

The titration procedure is stepwise and each step is documented:

Establish the room-air baseline at rest and confirm probe quality and waveform.

Perform the walk on room air; record the nadir SpO 2 _2 2 ​ , the time to nadir, symptoms, and the distance.

Rest until saturation and heart rate return to baseline.

Repeat the walk on supplemental oxygen, starting at a low flow such as 2 L/min and increasing in 1–2 L/min steps on subsequent walks until the SpO 2 _2 2 ​ stays at or above 88–90% throughout.

Document, without exception: the delivery device (nasal cannula, reservoir cannula, high-flow), the flow rate or pulse-dose setting , and who carried the tank — a patient carrying or pushing their own cylinder consumes more oxygen and walks a shorter distance than one whose tank is carried by the technologist, and that difference invalidates comparison between visits.

Pulse-dose (demand) conserving devices are not interchangeable with continuous flow. A conserver triggers on inspiratory effort; a patient who mouth-breathes during exertion may not trigger it reliably, so a setting that maintains saturation at rest can fail during a walk. Titration for ambulatory use must be performed with the actual device the patient will use.

Documenting the Data for Domain III

The reportable data set is the room-air resting SpO 2 _2 2 ​ , the nadir on room air with the workload that produced it, the flow rate required to maintain the target, the recovery time, and any discrepancy between the oximeter and a paired blood gas. Serial comparison across visits is only meaningful when device, carrying arrangement, and corridor are held constant.